Related references
Note: Only part of the references are listed.Impact of Patatin-Like Phospholipase-3 (rs738409 C>G) Polymorphism on Fibrosis Progression and Steatosis in Chronic Hepatitis C
Eric Trepo et al.
HEPATOLOGY (2011)
IL-28B predicts response to chronic hepatitis C therapy - fine-mapping and replication study in Asian populations
Hidenori Ochi et al.
JOURNAL OF GENERAL VIROLOGY (2011)
Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis C
Hans L. Tillmann et al.
JOURNAL OF HEPATOLOGY (2011)
Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosis
Tao Cai et al.
JOURNAL OF HEPATOLOGY (2011)
Amino acid substitutions in core and NS5A regions of the HCV genome can predict virological decrease with pegylated interferon plus ribavirin therapy
Shosuke Kitamura et al.
ANTIVIRAL THERAPY (2010)
A predictive model of response to peginterferon ribavirin in chronic hepatitis C using classification and regression tree analysis
Masayuki Kurosaki et al.
HEPATOLOGY RESEARCH (2010)
Common variation of IL28 affects gamma-GTP levels and inflammation of the liver in chronically infected hepatitis C virus patients
Hiromi Abe et al.
JOURNAL OF HEPATOLOGY (2010)
Decrease in the Prevalence of Adolescent Alcohol Use and its Possible Causes in Japan: Periodical Nationwide Cross-Sectional Surveys
Yoneatsu Osaki et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2009)
Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C: a Japanese multi-center study
Takeshi Okanoue et al.
JOURNAL OF GASTROENTEROLOGY (2009)
A Matched Case-Controlled Study of 48 and 72 Weeks of Peginterferon Plus Ribavirin Combination Therapy in Patients Infected With HCV Genotype 1b in Japan: Amino Acid Substitutions in HCV Core Region as Predictor of Sustained Virological Response
Norio Akuta et al.
JOURNAL OF MEDICAL VIROLOGY (2009)
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Dongliang Ge et al.
NATURE (2009)
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Vijayaprakash Suppiah et al.
NATURE GENETICS (2009)
Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
Yasuhito Tanaka et al.
NATURE GENETICS (2009)
Verification of the Addiction Severity Index Japanese Version (ASI-J) as a Treatment-Customization, Prediction, and Comparison Tool for Alcohol-Dependent Individuals
Ayako Haraguchi et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2009)
Predictors of viral kinetics to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b
Norio Akuta et al.
JOURNAL OF MEDICAL VIROLOGY (2007)
Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: Amino acid substitutions in the core region and low-density lipoprotein cholesterol levels
Norio Akuta et al.
JOURNAL OF HEPATOLOGY (2007)
Prediction of response to pegylated interferon and ribavirin in hepatitis C by polymorphisms in the viral core protein and very early dynamics of viremia
Norio Akuta et al.
INTERVIROLOGY (2007)
Steatosis in chronic hepatitis C: Why does it really matter?
T Asselah et al.
GUT (2006)
Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype1b and high viral load
N Akuta et al.
JOURNAL OF MEDICAL VIROLOGY (2006)
E2 of hepatitis C virus inhibits apoptosis
SH Lee et al.
JOURNAL OF IMMUNOLOGY (2005)
Hepatic steatosis in chronic hepatitis B and C: Predictors, distrihution and effect on fibrosis
A Gordon et al.
JOURNAL OF HEPATOLOGY (2005)
Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 1b high viral load and non-virological response to interferon-ribavirin combination therapy
N Akuta et al.
INTERVIROLOGY (2005)
Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease
A Lonardo et al.
GASTROENTEROLOGY (2004)
Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin
JH Hoofnagle et al.
HEPATOLOGY (2003)
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
MW Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
MP Manns et al.
LANCET (2001)
Risk factors of hepatitis C virus-related liver cirrhosis in young adults: Positive family history of liver disease and transporter associated with antigen processing 2 (TAP2)*0201 allele
N Akuta et al.
JOURNAL OF MEDICAL VIROLOGY (2001)
Share Paper
